Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Cryotherapy for Paclitaxel-Induced Neuropathy in Breast Cancer
NCT03429972Phase 2Unknown
- Sponsor
- National Cancer Centre Singapore
- Start
- Sep 2016
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by National Cancer Centre Singapore. Primary endpoint: Patient Neurotoxicity Questionnaire at 3 months. Status: unknown.
Beyond the preview
Go deeper on NCT03429972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03429972.